rs141963371
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The NM_001127222.2(CACNA1A):āc.5986A>Gā(p.Thr1996Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000543 in 1,510,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001127222.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1A | NM_001127222.2 | c.5986A>G | p.Thr1996Ala | missense_variant | 41/47 | ENST00000360228.11 | NP_001120694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.5986A>G | p.Thr1996Ala | missense_variant | 41/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6004A>G | p.Thr2002Ala | missense_variant | 42/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.5992A>G | p.Thr1998Ala | missense_variant | 41/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.5989A>G | p.Thr1997Ala | missense_variant | 41/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.5989A>G | p.Thr1997Ala | missense_variant | 41/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.5989A>G | p.Thr1997Ala | missense_variant | 41/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.5848A>G | p.Thr1950Ala | missense_variant | 40/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.5989A>G | p.Thr1997Ala | missense_variant | 41/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.6004A>G | p.Thr2002Ala | missense_variant | 42/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.5995A>G | p.Thr1999Ala | missense_variant | 42/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.5992A>G | p.Thr1998Ala | missense_variant | 41/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.5989A>G | p.Thr1997Ala | missense_variant | 41/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.5989A>G | p.Thr1997Ala | missense_variant | 41/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.5989A>G | p.Thr1997Ala | missense_variant | 41/46 | 5 | ENSP00000489777.1 | |||
CACNA1A | ENST00000636768.1 | n.*288A>G | non_coding_transcript_exon_variant | 6/10 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000636768.1 | n.*288A>G | 3_prime_UTR_variant | 6/10 | 5 | ENSP00000490190.2 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151990Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000489 AC: 8AN: 163620Hom.: 0 AF XY: 0.0000462 AC XY: 4AN XY: 86494
GnomAD4 exome AF: 0.0000552 AC: 75AN: 1358594Hom.: 0 Cov.: 33 AF XY: 0.0000572 AC XY: 38AN XY: 664366
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74358
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 29, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 16, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | CACNA1A: PP2 - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.5989A>G (p.T1997A) alteration is located in exon 41 (coding exon 41) of the CACNA1A gene. This alteration results from a A to G substitution at nucleotide position 5989, causing the threonine (T) at amino acid position 1997 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at